Algal DHA and ARA Market Was Valued at USD 1,137.90 Mn in 2033

Global algal DHA and ARA market was valued at USD 738.20 Mn in 2026. Algal DHA and ARA market is expected to register a CAGR of 7.47% over the forecast period (2026–2033), to reach USD 1,137.90 Mn by 2033.

Global Algal DHA and ARA Market was valued at USD 738.20 Mn in 2026, According to algal DHA and ARA Market Report, by Form (Oil and Powder), by Application (Infant Formula, Nutritional Supplements, Animal Feed, and Food & Beverages), and by Region (North America, Latin America, Asia Pacific, Europe, Middle East and Africa), published by Coherent Market Insights

Increasing number of campaigns’ promoting organic food by government bodies along with growing awareness about adverse health effects of chemical contaminants on infant health is expected to propel demand for organic baby food during the forecast period, aiding the growth of algal DHA and ARA market. Algal oils are source of docosahexaenoic acid (DHA) for functional food fortification and infant formulas. Increasing adoption of dietary supplements coupled with growing awareness regarding benefits of dietary supplements in curing chronic diseases and weight management are fuelling growth of the global algal DHA and ARA market. According to Council for Responsible Nutrition, 68% of the American population consumed dietary supplements in 2020. Presence of various alternative sources of extraction of DHA and ARA such as fungi, fish oil, krill oil, and dairy products are hindering growth of DHA and ARA extracted from algae

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/algal-dha-and-ara-market-2346

Browse 50 market data tables* and 40 figures* on "Global Algal DHA and ARA Market” - Forecast to 2033.

Key Trends and Analysis of the Global Algal DHA and ARA Market

• Among regions, North America accounted for a significant market share of 36.80% in 2026. Government regulations for the use of algal DHA and ARA in infant nutrition, food & beverages, and nutritional supplement industries is driving growth of the algal DHA and ARA market. The government bodies such as the United Nations Food and Agriculture Organization/World Health Organization (FAO/WHO) approved DHA and ARA for infant nutrition. Thus, manufacturers are focusing on developing DHA- and ARA-based products in infant nutrition industry.
• Asia Pacific is expected to be the fastest growing region in the algal DHA and ARA market during the forecast period. This region has countries with the largest population and birth rates in the world. According to the United Nations, there were 675 million infants in 2020, globally. Moreover, Asia Pacific accounts for around half of the world’s infant population in 2020. This in turn is increasing demand for infant nutrition products, which includes algal DHA and ARA thereby fuelling growth of the market.

Key News

• In May 2026, Fermentalg, microalgae-based biotechnology company launched Omega Origins, a high-potency algal omega-3 oil containing 40% EPA and 20% DHA. Developed through a patented fermentation process using its proprietary Schizochytrium limacinum FCC-3204 microalgae strain, the product delivers naturally concentrated EPA and DHA without additional concentration steps. The oil targets sports nutrition and longevity applications, supporting smaller capsules and formats such as softgels, gummies, powders, emulsions, and liquids for supplement brands globally market.
• In April 2026, Corbion N.V., food company received a new U.S. patent for omega-3 fatty acids derived from algae, strengthening its algal fermentation platform. The patent covers a liquid suspension of lysed algal cells in oil with a DHA-rich profile, improving stability and performance in feed applications. The innovation supports AlgaPrime DHA LS across aquaculture, animal nutrition, and pet food while reducing reliance on ocean-based resources and enhancing sustainable ingredient supply chains globally.
• In February 2026, GC Rieber VivoMega, a company that manufactures highly concentrated omega-3 oil launched Algae 1045 TG, a high-potency vegan omega-3 algal oil combining DHA and EPA in triglyceride form. The ingredient targets nutraceutical brands seeking plant-based, clean-label alternatives with strong bioavailability, purity, and sensory performance. Produced through the company’s SuperLight processing technology, the oil supports oxidation protection, resource efficiency, and minimal-to-zero waste while expanding VivoMega’s sustainable omega-3 portfolio for global supplement applications and finished product formulations.
• In January 2026, Aker BioMarine, company that supply natural and powerful krill ingredients for human health and nutrition announced plans to strengthen its omega-3 presence in India at Vitafoods India 2026 through local leadership, product innovation, and a new distribution partnership with G.C. Chemie Pharmie. The collaboration will expand access to Superba Krill oil and Revervia, its algae-derived DHA ingredient, across Indian nutraceutical brands. Revervia supports vegetarian, sustainable omega-3 formulations for brain, eye, maternal, and fetal health applications.

Key Takeaways of the Global Algal DHA and ARA Market

• According to Coherent Market Insights in 2026, among application, infant formula segment held largest revenue share of 40% in the global algal DHA and ARA market in 2026. Owing to its various health benefits such as its consumption supports healthy pregnancy, visual development and function, cardiovascular health, and memory. Increasing demand for DHA and ARA from formula market is driving growth of the segment in the algal DHA and ARA market. Algal DHA and ARA is a major source of unsaturated omega 3 fatty acids, which is used as a nutritional supplement for infant nutrition.
• Oil form segment accounted for the largest market share in the global algal DHA and ARA market in 2026. Utilization of DHA and ARA in nutritional supplement is propelling demand for algal DHA oil, as it is unsaturated omega 3 fatty acids, which is used for various applications. DHA and Eicosapentaenoic acid (EPA) from algal oil sources are used for various applications in infant formulas, nutritional supplements, and foods & beverages industries. It may also be used where formulating with fish oils may be a problem due to lack of fish stock, as supplement for pregnant and nursing women due to smell and supplement and food for vegetarian consumers. These factors are expected to boost growth of algal DHA and ARA oil in the global market.